ERBB2 and breast cancer: Strikingly, miR-155, a well-known key modulator in BC carcinogenesis, has been found to downregulate ErbB2 by directly or indirectly targeting HDAC2, a transcriptional activator of ErbB2 in BC, closely regulating cell survival, growth, and chemosensitivity [76].